Susquehanna Fundamental Investments’s Champions Oncology CSBR Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,449	Closed	-$97.2K	–	423
2023 Q2	$97.2K	Sell	15,449 -5,170	-25%	-$26.7K	﹤0.01%	608
2023 Q1	$82.9K	Sell	20,619 -2,481	-11%	-$10.6K	﹤0.01%	908
2022 Q4	$104K	Hold	23,100	–	–	﹤0.01%	1115
2022 Q3	$173K	Buy	+23,100	New	+$193K	﹤0.01%	1281
2022 Q1	$219K	Sell	26,935 -914	-3%	-$7.33K	﹤0.01%	1338
2021 Q4	$223K	Sell	27,849 -533	-2%	-$4.91K	0.01%	1205
2021 Q3	$290K	Hold	28,382	–	–	0.01%	1419
2021 Q2	$292K	Buy	+28,382	New	+$288K	0.01%	1378

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna Fundamental Investments's CSBR Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Champions Oncology (CSBR) in Q3 2023, closing a stake of 15,449 shares — an estimated $97.2K sold.

Susquehanna Fundamental Investments first reported a position in CSBR in Q2 2021 and held it in 8 quarters. The position peaked at $292K in Q2 2021. 29 funds tracked by Wall St. Rank hold CSBR as of Q3 2023.

Susquehanna Fundamental Investments reported no remaining Champions Oncology position as of Q3 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 15,449 Champions Oncology shares in Q3 2023, an estimated $97.2K.
Susquehanna Fundamental Investments first reported a position in Champions Oncology in Q2 2021 and held it in 8 quarters.
Susquehanna Fundamental Investments's Champions Oncology position peaked at $292K in Q2 2021.
29 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.